PTIX
Protagenic Therapeutics, Inc.$0.6480 −0.07 (−10.00%)
Oct 26 4:00 PM ET · prev $0.7200
Next earnings
Nov 24
in 28 days
1 year
−78.3%
from $2.98 · Oct 27
30 days
−16.9%
from $0.7800
52-week range
$0.1280–2.98
−78% from high · low Jul 29
Avg volume 20D
1.0K
Oct 1 spike 5.7K
Short interest
🔒 Subscribers only
Insider net
+$30.7K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read BULLISH 1 report · 90 days
Balance 0 bearish · 1 bullish oldest → newest, height = score
Avg score ·Next Earnings date, Nov 24, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- B Jul 30 to Aug 11 4 days of insider buys: $7.0K by 1 insider, avg $0.2036
- B Aug 19 to Aug 21 3 days of insider buys: $23.8K by 1 insider, avg $0.6039
- R Aug 20 Protagenic Therapeutics received written FDA pre-IND feedback for it…
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $30.7K at an average $0.4177. No open-market sales. Price is 55% above their cost.
- InstitutionsMIXED
Q4 2025: 1 added (0 new), 1 trimmed or exited.
- TrendDOWNTREND
21% below its 50-day average.
Who's buying
13F· Q4 20250
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| BANK OF AMERICA CORP /DE/ | DOUBLED | $22.00 |
| MORGAN STANLEY | NEAR_EXIT | $2.00 |
| CITIGROUP INC | DOUBLED | $6.1K |
| UBS Group AG | NEAR_EXIT | $192.00 |
| BANK OF AMERICA CORP /DE/ | ADD | $27.00 |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $15.1K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $21.8K |
| UBS Group AG | ADD | $7.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Insider ledger
Form 4$30.7K
bought · 1 insider
$0
sold · 0 insiders
+55.1%
vs their $0.4177 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 21, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | BUY | $13.0K |
| Aug 20, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | BUY | $9.8K |
| Aug 19, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | BUY | $945.00 |
| Aug 11, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | BUY | $710.40 |
| Aug 6, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | BUY | $150.70 |
| Aug 5, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF | BUY | $1.3K |
| Jul 30, 2026 | ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF. | BUY | $4.8K |
Earnings setup
EstimatesNov 24
reports in 28 days
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 21, 2026 Insider
Aug 20, 2026 SEC ARMEN GARO H bought 20,000 shares
EXEC. CHAIR & PRINCIPAL OFF @ $0.6500 ($13.0K)
Protagenic Therapeutics received written FDA pre-IND feedback for its lead candidate PT00114 in generalized anxiety…
8-K — Impact 6/10
Aug 20, 2026 Insider
ARMEN GARO H bought 16,634 shares
EXEC. CHAIR & PRINCIPAL OFF @ $0.5898 ($9.8K)
Aug 19, 2026 Insider
ARMEN GARO H bought 2,700 shares
EXEC. CHAIR & PRINCIPAL OFF @ $0.3500 ($945.00)
May 13, 2026 Earnings calendar
PTIX Q4 2026 Earnings Scheduled — 2026-05-13
Dec 31, 2025 Inst.
BANK OF AMERICA CORP — DOUBLED
17 shares ($22.00)
Dec 31, 2025 Inst.
MORGAN STANLEY — NEAR_EXIT
2 shares ($2.00)
SecBot reports
1 filing · 1 bullish · 0 bearishAll PTIX filing & press-release reports (1)
- 8-K reportAug 20, 2026